Plasma Fractionation Market to Witness Huge Growth by Key Players: CSL, Grifols, Shire, Octapharma, Kedrion, BPL, Sanquin, LFB and Others.

The Plasma Fractionation Market report shows the competitive situation among the top manufacturers, with sales, revenue and market share and the market by type and application, with sales market share and growth rate by type, application, from 2019 to 2024

The Global Plasma Fractionation Market is projected to reach USD 34.9 Billion by 2024 from USD 25.4 Billion in 2019, at a CAGR of 6.6% during the forecast period.


Key Players- CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), BPL (UK), Sanquin (Netherlands), LFB (France), Biotest (Germany), Japan Blood Products Organization, China Biologic Products (China), Green Cross Corporation (South Korea), and Shanghai RAAS Blood Products (China).

The immunoglobulin segment is expected to dominate the plasma fractionation market during the forecast period. IVIg is the most extensively used plasma product across the globe, meant for the treatment of dermatomyositis, Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), immune cytopenias, hypogammaglobinemia, primary antibody deficiency, vacuities, multiple sclerosis, asthma, and systemic lupus erythematosus, among other ailments.

The coagulation factor market is segmented into factor VIII, factor IX, Von Willebrand factor, prothrombin factor concentrates, fibrinogen concentrates, and factor XIII. Factor VIII segment is expected to hold the largest share in the coagulation factor concentrates market in 2019.

Table of Contents:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Scope of the Study

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency

1.5 Stakeholders

Special Offers (Buy this report and Get 30% Off) @

2 Research Methodology

2.1 Research Approach

2.1.1 Secondary Sources Key Data From Secondary Sources

2.1.2 Primary Sources Primary Sources Key Data From Primary Sources Key Industry Insights

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach

2.3 Market Breakdown and Data Triangulation

2.4 Market Share Estimation

2.5 Assumptions for the Study

2.6 Limitations

3 Executive Summary

4 Premium Insights

4.1 Plasma Fractionation Market Overview

4.2 Geographical Snapshot of the Plasma Fractionation Market

4.3 Plasma Fractionation Market: Regional Mix

4.4 Plasma Fractionation Market, Developing Countries vs Developed Countries

5 Market Overview


List of Tables:

Table 1 Plasma Fractionation Market: Impact Analysis

Table 2 On-Label and Off-Label Indications of IVIg

Table 3 Number of Clinical Studies on Immunoglobulins, By Region, 2017

Table 4 Number of Patients Treated for Top 10 Target Conditions in the UK (2015-16)

Table 5 Increase in Geriatric Population From 2000 to 2050 Across the Globe

Table 6 Number of Plasma Collection Centers, By Company, 2018

Table 7 Number of Hemophilia Patients in Developed and Emerging Countries, 2016 vs 2017

Table 8 Increasing Consolidation and Rising Adoption of SCIg are the Leading Industry Trends

Table 9 Fractionation Capacity Expansions By Major Players

Table 10 Per Capita Consumption of IVIg and Albumin, By Country (2014)

Table 11 China: Top Players in the Plasma Fractionation Market, 2018

Table 12 Major Local Players in China

Table 13 Regional Impact Analysis of Recombinant Factors on Plasma-Derived Products

Table 14 Average Selling Price of Plasma Fractionation Products, By Player (2018)

Table 15 Average Selling Price of Plasma Fractionation Products, By Region (2018)

…and More

Any Doubt or Need Customization Report @